Can a new drug stop transplant complications?
NCT ID NCT04572815
First seen Dec 12, 2025 · Last updated May 25, 2026 · Updated 29 times
Summary
This study tests whether the drug ustekinumab can prevent a serious side effect called graft-versus-host disease (GVHD) in adults receiving stem cell transplants for blood cancers. GVHD occurs when donor cells attack the patient's body. The trial involves 116 participants who receive either ustekinumab or a placebo after transplant. The goal is to see if the drug reduces severe GVHD and improves survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHOID SYSTEM NEOPLASM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope Comprehensive Cancer Center,
Duarte, California, 91010, United States
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
-
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida, 33612, United States
-
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
Conditions
Explore the condition pages connected to this study.